CorMedix Inc.

CRMD XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

640M

Short interest (May 15)

19.8%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.66%

↓ 1.2%

Available Shares

200K

↓ 50.8%

Price Chart

Company Overview

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001410098

Asset Type: CS

Market Data

Market Cap: $640,951,949

Employees: 191

Status: Active

Short Interest

Current Borrow Fee 0.66%

Range: 0.65% - 0.74%

Available Shares 200K

Range: 200K - 300K

Recent Changes

Fee Change: ↑ 2.7%

Available Change: ↓ 16.7%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime